Speech-Language Pathologists in Downingtown, PA Accepting Medicare
71 Speech-Language Pathologists found. Showing 61 - 71
 Catherine B Doran, MA CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 455 Boot Rd, Downingtown, PA 19335 Phone: 484-237-5134 |
Ms. Jaclyn Kubala, M.S. Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 455 Boot Rd, Downingtown, PA 19335 Phone: 484-237-1000 |
Elissa Steinke Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 455 Boot Rd, Downingtown, PA 19335 Phone: 484-237-5150 |
Kristina Kubala, M.S. CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 455 Boot Rd, Downingtown, PA 19335 Phone: 484-354-5354 |
Mrs. Erin Kyler, M.A., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 455 Boot Rd, Downingtown, PA 19335 Phone: 484-237-5150 |
Jessica Fabry, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 455 Boot Rd, Downingtown, PA 19335 Phone: 484-237-5150 |
Mrs. Lindsay Ambrosino, MA CCC SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 455 Boot Rd, Downingtown, PA 19335 Phone: 484-237-5159 |
 Chester County Intermediate Unit Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 455 Boot Rd, Downingtown, PA 19335 Phone: 484-237-5150 |
Rebecca Hermann, M.S. CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 427 Crestwood Ln, Downingtown, PA 19335 Phone: 717-951-3922 |
Mrs. Michelle Mcentee Graham, MA CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 455 Boot Rd, Downingtown, PA 19335 Phone: 484-237-5150 |
Mrs. Jeanette Hoover Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 455 Boot Rd, Downingtown, PA 19335 Phone: 484-237-5150 |
News Archive
Conatus commences multi-center CTS-1027 Phase 2b trial for HCV treatment
Conatus Pharmaceuticals Inc. announced today the treatment of the first patient in a multi-center Phase 2b clinical trial evaluating CTS-1027 in combination with Peginterferon Alfa-2a and ribavirin in a treatment experienced, hepatitis C null responder patient population. Safety, tolerability, and antiviral activity of the triple combination will be assessed after up to 48 weeks of therapy.
People with type 2 diabetes, OSA may not experience improved glycemic control with CPAP
People with type 2 diabetes and obstructive sleep apnea (OSA) may not experience improved glycemic control by using continuous positive airway pressure, or CPAP, as some studies have suggested, according to the results of a randomized, controlled trial published online ahead of print in the American Thoracic Society's American Journal of Respiratory and Critical Care Medicine.
New draft guidance addresses FDA's oversight of foods covered by Systems Recognition Arrangement
In order to fulfill our public health mission and enhance the safety of imported foods in a global world, we must embrace new approaches that take into account the entire supply chain and its complexity.
More PMTCT interventions needed, experts at WHO Regional meeting say
Experts participating in the 59th session of the WHO Regional Committee for Africa called for more interventions to prevent mother-to-child HIV transmission (PMTCT), New Times/allAfrica.com reports.
› Verified 9 days ago
Speech-Language Pathologists
Physical Therapists
Chiropractors
Occupational Therapists
Optometrists
Podiatrists
Audiologists